AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
If you want tighter expense control and explicit assignment of funds, zero based budgeting can be worth trying. This intro explains potential gains and a simple starting point.
26,943 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
A surprise-dropped opener can feel sudden, but your finances don’t have to react in panic. Learn a practical plan to ...
As 2026 opens with mixed signals, investors seek ballast. This story examines three dividend ETFs that actually shiel...
Florida advances a bill to license stablecoin issuers and oversee the market at the state level, signaling a potentia...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...
Revived cross-border pipeline plans fuse old routes into a modern energy corridor, with potential ripple effects on p...
Binance founder Changpeng Zhao addresses social media chatter claiming a Dubai surfing accident, calling the reports ...
Semiconductor ETFs are leading the charge on U.S. exchanges, pushing chip-focused funds onto the most-traded lists. T...
A 25-year-old has amassed a $500k stock portfolio, 13 rental properties, and about $10,000 in monthly gross income wh...
When new Berkshire leadership takes the reins, investors wonder which names could ride along. Here’s why a flavor-foc...
DocMagic promotes Leah Sommerville to director of sales, signaling a bold push toward enterprise-wide paperless closi...
The Ethereum Foundation has begun staking a portion of its treasury, deploying 2,016 ETH as part of a broader move in...